FDA NDC Directory · JSON-LD · Markdown

DOBUTAMINE

NDC 51662-1337 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryAbbreviated NDA (generic) · App ANDA074086
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsDOBUTAMINE HYDROCHLORIDE (12.5 mg/mL)
Marketing started20181126
Package count2

External sources

Source: openFDA. Public-domain (CC0).